Pemphigoid diseases (including bullous pemphigoid, mucous membrane pemphigoid,
pemphigoid gestationis, linear IgA dermatosis, lichen planus pemphigoides, and anti-p200 …

Mucous membrane pemphigoid (MMP) is a systemic cicatrizing autoimmune disease that
primarily affects orificial mucous membranes, such as the conjunctiva, the nasal cavity, the …

Cicatricial pemphigoid. - PMC Back to Top Skip to main content NIH NLM Logo Access keys
NCBI Homepage MyNCBI Homepage Main Content Main Navigation Preview improvements …

Designed with practical usability in mind, Comprehensive Dermatologic Drug Therapy, 4th
Edition, helps you safely and effectively treat the skin disorders you're likely to see in your …

PURPOSE: To compare the effectiveness and safety of the combination therapy of rituximab
(RTX) and intravenous immunoglobulin (IVIg) to other immunosuppressive regimens in the …

PURPOSE: To evaluate the effectiveness and toxicity of a stepladder immunosuppression
strategy, including the use of mycophenolate mofetil and combination therapy, in the …

The pemphigoid group is a category of autoimmune subepidermal blistering diseases in
which autoantibodies deposit linearly at the epidermal basement membrane zone (BMZ) …

Background Mucous membrane pemphigoid and epidermolysis bullosa acquisita are rare
acquired autoimmune blistering diseases of the skin. Both can result in scarring of mucous …

Intravenous immunoglobulins (IVIg) were first introduced in the middle of the twentieth
century for the treatment of primary immunodeficiencies. In 1981, Paul Imbach noticed an …

Ocular inflammatory disease is the third leading cause of blindness in the United States. In
addition to the conventional immunomodulatory agents, which include antimetabolites …